Want to join the conversation?
$HCP cut its 2015 FFO per share guidance to $1.74-1.80 from previous forecast of $1.97-2.03 and adjusted FFO per share outlook to $3.12-3.18 from prior estimate of $3.14-3.20. EPS is now expected to be $0.52-0.58, down from prior guidance of $0.75-0.81. $HCP still expects same property portfolio cash net operating income to rise 0-1%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.